None listed
Conditions
Interventions
None listed
Sponsors
Kyung Hee University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: • 19 years of age or older • Pancreatic cancer (neoplasm) was confirmed by biopsy • Who are diagnosed as stage 3 or 4 of TNM staging based on the 8th edition of the AJCC, and are inoperable • Who are scheduled for combination treatment with 5-FU or gemcitabine-based/mono first palliative chemotherapy and traditional Korean medicine including Rhus verniciflua stokes or within 2 months of starting the treatment • Whose life expectancy is more than 3 months • The Eastern Cooperative Oncology Group (ECOG) performance status score 0-2 • Those who understand the research content and agree to participate in the research
Exclusion criteria
Exclusion criteria: • Pregnant women, lactating women • Patients with active brain metastases showing clinically significant neurological symptoms or signs •Those who have clinically significant skeletal related events, including pathological fractures and spinal cord compressions, and require radiotherapy or surgical therapy •Those who have been diagnosed with other new primary cancers that may affect the patient's condition within the last 5 years •Who are judged to be inappropriate for the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms and incidence of adverse events based on CTCAE ver 5.0 | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression free survival;Time to metastasis;overall response rate based on RECIST;overall survival;disease related overall survival;Early end rate according to CTCAE grade 3 or higher;EORTC QLQ C30 (quality of life questionnaire);Pattern questionnaire for tradition Korean medicine | — |
Countries
Korea, Republic of
Contacts
Public ContactEun Hye Kim
Kyung Hee University Oriental Medicine Hospital at Gangdong
Outcome results
None listed